Key result
Genetic testing identifies a novel homozygous ABCG8 deletion confirming sitosterolemia in pediatric hyperlipidemia.
Why the study?
Sitosterolemia is a rare autosomal recessive disorder whose hematologic abnormalities on routine complete blood counts are often overlooked, while biochemical studies frequently mimic hyperlipidemia.
Case Report (n=1)
No
This case report identifies a novel homozygous exon 2 to 3 deletion in ABCG8 causing sitosterolemia, highlighting the need to consider this rare condition in patients presenting with hyperlipidemia accompanied by unexplained hemolytic anemia and macrothrombocytopenia.
Answers are grounded in this paper and cite their sources.
May prompt sitosterolemia evaluation in unexplained hyperlipidemia; leaves open mutation prevalence and clinical impact.
INTRODUCTION Sitosterolemia is a rare autosomal recessive disorder characterized by hypercholesterolemia, tendon and tuberous xanthomas, premature atherosclerosis, hemolytic anemia, and macrothrombocytopenia. Hematologic abnormalities are typically detected on routine complete blood counts and are often overlooked. Biochemical studies frequently reveal findings similar to hyperlipidemia. In sitosterolemia, elevated plasma plant sterol levels are observed. Definitive diagnosis can be established by identifying homozygous or compound heterozygous pathogenic variants in ABCG5 and/or ABCG8. CASE REPORT The index case was a 6-year-old Turkish girl referred to our clinic because of elevated total and low-density lipoprotein cholesterol levels detected during follow-up. Physical examination revealed no xanthomas or other abnormal findings. Complete blood count and peripheral blood smear demonstrated anemia, macrothrombocytopenia, and stomatocytosis. Based on the clinical and laboratory findings, sitosterolemia was suspected and subsequently confirmed by detection of a novel homozygous pathogenic variant, exon 2 to 3 deletion, in ABCG8. CONCLUSION Sitosterolemia can be managed with dietary modification and, if necessary, the use of ezetimibe, a sterol absorption inhibitor, if diagnosed early. Sterol levels can be reduced by 10% to 50%. It is crucial to consider sitosterolemia in the differential diagnosis of patients with unexplained hemolytic anemia and macrothrombocytopenia accompanying hyperlipidemia.
No takes yet. Share an insight, caveat, or question.
Guler et al. (2026) conducted a case report in Sitosterolemia (presenting with hyperlipidemia, anemia, macrothrombocytopenia, and stomatocytosis) (n=1). Genetic testing for ABCG8 / dietary modification and ezetimibe was evaluated on Genetic confirmation of sitosterolemia. Genetic testing in a 6-year-old girl with hyperlipidemia, anemia, and macrothrombocytopenia identified a novel homozygous exon 2 to 3 deletion in ABCG8, confirming sitosterolemia.
Synapse has enriched 10 related papers. Consider them for comparative context: